This week’s View examines specific effects of systolic and diastolic blood pressure on various CV outcomes, the impact of hypertensive disorders of pregnancy on the onset of chronic hypertension in the first years following first pregnancy, and a look at how far we’ve come in contemporary PCI, a comparison of SYNTAX II versus SYNTAX I.   Subscribe to Eagle’s Eye View

Eagle's Eye View: Your Weekly CV Update From ACC.org

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Oct. 18)

This week’s View focuses on hypertension treatment intensification in older adults, key points on physical activity and exercise in patients with spontaneous coronary artery dissection and fibromuscular dysplasia, and CV disease risk among cigarette smokers who transitioned to vaping. Subscribe to Eagle’s Eye View

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of October 11)

This week’s View focuses on prevention: the association of statin therapy initiation and diabetes progression, the relationship between target BP and outcomes in patients with left ventricular hypertrophy, and the effects of lifestyle modifications in patients with resistant hypertension. Subscribe to Eagle’s Eye View

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Oct. 4)

This week’s View focuses on the effect of neprilysin inhibition on BP in patients with HFpEF and resistant hypertension, three- vs. two-drug therapy for patients with newly diagnosed pulmonary artery hypertension, and early invasive angiography in acute HF.

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of September 27)

This week's View summarizes articles on empagliflozin improving CV outcomes irrespective of blood pressure, the efficacy of the COVID-19 vaccine at 6 months post-vaccination, and the protection of the COVID-19 booster dose in Israel.

Eagle's Eye View: Your Weekly CV Update From ACC.org (Week of September 20)

This week’s View summarizes articles about whether there are differences in daily symptom scores on statin, placebo, and no treatment in participants who had abandoned statins; the safety and immunogenicity of heterologous schedules with different coronavirus disease 2019 (COVID-19) vaccines; and the effectiveness of inhaled budesonide in reducing recovery time and rates of COVID-19-related hospital admission or death in people at high risk of an adverse outcome.

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of September 13)

This week’s View summarizes articles about whether acute alcohol consumption increases the risk of a discrete atrial fibrillation (AF) episode, whether continuous cardiac rhythm monitoring beyond hospital discharge enhances AF detection among cardiac surgical patients, and if the addition of aspirin in fixed-dose combination treatment is associated with reductions for cardiovascular disease outcomes.

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of September 6)

In this special episode of Eagle’s Eye View, Dr. Deepak Bhatt, Dr. Gabriel Steg, and Dr. Carolyn Lam discuss highlights from Day 4 of ESC Congress 2021, including IAMI, STEP, Amulet IDE, PRONOUNCE, and STOPDAPT-2 ACS.

Eagle’s Eye View: Day 4 Highlights | ESC Congress 2021

In this special episode of Eagle’s Eye View, Dr. Deepak Bhatt and Dr. Gabriel Steg discuss highlights from Day 3 of ESC Congress 2021, including TWILIGHT-HBR, The Michelle Trial, ECLA PHRI COLCOVID, and PREPARE-IT.

Eagle’s Eye View: Day 3 Highlights | ESC Congress 2021

In this special episode of Eagle’s Eye View, Dr. Deepak Bhatt and Dr. Gabriel Steg discuss highlights from Day 2 of ESC Congress 2021, including MASTER DAPT, ENVISAGE-TAVI AF, and FIGARO-DKD.

Eagle’s Eye View: Day 2 Highlights | ESC Congress 2021

In this special episode of Eagle’s Eye View, Dr. Deepak Bhatt, Dr. Gabriel Steg, and Dr. Carolyn Lam discuss highlights from Day 1 of ESC Congress 2021, including EMPEROR-Preserved, EMPEROR-Pooled, GUIDE-HF, and the ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.

Eagle’s Eye View: Day 1 Highlights | ESC Congress 2021

This week’s View offers key points from a state-of-the-art review on management of acute cardiovascular complications in pregnancy, summarizes an article about pregnancy-associated vascular complications in Marfan syndrome, and analyzes a subgroup analysis looking at the risk for major adverse cardiovascular events in relation to prior acute coronary syndrome and the benefits of colchicine.

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of August 23)

In this week’s View, guest host Deepak Bhatt, MD, MPH, FACC, offers a preview of some of the hottest trials at the European Society of Cardiology Congress 2021, taking place virtually August 27-30, including IAMI, EMPEROR-Preserved, EMPEROR-Pooled, MASTER DAPT, ENVISAGE-TAVI AF, FIGARO-DKD, FIDELITY, Colchicine in Patients Hospitalized with COVID-19, PREPARE-IT, The Michelle trial, GUIDE-HF, QUARTET, TWILIGHT-HBR, PRONOUNCE, and Amulet IDE.

Eagle's Eye View: Your Weekly CV Update From ACC.org (ESC Congress 2021 Preview)

This week’s View covers articles about the features and outcomes of post-vaccination cerebral venous thrombosis with and without vaccine-induced thrombotic thrombocytopenia, whether a Mediterranean dietary pattern reduces atherosclerosis among patients with established coronary heart disease, and the natural history of asymptomatic penetrating aortic ulcer.

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of August 16)

In this week’s View, guest host Deepak Bhatt, MD, MPH, FACC, reviews articles about the risk of acute myocardial infarction and ischemic stroke associated with coronavirus disease 2019 (COVID-19) among all COVID-19 cases in Sweden, a sub-analysis from the Early Treatment of Atrial Fibrillation for Stroke Prevention Trial, and whether the cumulative intake of a plant-centered diet is associated with incident cardiovascular disease.

Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of August 9)

The weekly cardiovascular update from ACC.org Editor-in-Chief Kim Eagle, MD, MACC, covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.

hubhopper

Eagle's Eye View: Your Weekly CV Update From ACC.org

hubhopper